TG Therapeutics società ha sostenuto
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. leggi di più
HR or Marketing? Claim Your Free Employer Account
My compensation package in most cases exceeds the industry average and I'm very happy with compensation and benefits.
Che cosa ti rende più felice sul posto di lavoro?
We all work very well together, we've been together for years and by working together we are exponentially better.
Cosa ti piace di più del team di leadership?
From the day I started, the Leadership Team has done everything possible to make TG a standout company. The work environment is excellent and they truly care about every employee!
La cosa più positiva della cultura e l'ambiente presso la tua azienda?
We all work very hard, but with our goals in mind. And it's great to see how TG has been hitting it's bench marks year after year - it helps keep everyone's morale up!
Other Employee Reviews for TG Therapeutics
×